Australian Airlines Stock News

ASX:ONE
ASX:ONEHealthcare Services

Oneview Healthcare H1 Loss Worsens Challenging Bullish Revenue Growth Narratives

Oneview Healthcare (ASX:ONE) has put fresh numbers on the table for FY 2025, reporting first half revenue of €6.3 million and a basic EPS loss of €0.01. Trailing twelve month revenue stands at €11.6 million with a basic EPS loss of €0.016452. Over recent periods the company’s revenue has moved from €4.7 million in the first half of 2024 to €5.2 million in the second half of 2024 and then to €6.3 million in the first half of 2025. Across the same periods, half year basic EPS figures have...
ASX:CAR
ASX:CARInteractive Media and Services

Assessing CAR Group (ASX:CAR) Valuation After Strong Earnings Growth And AI Expansion

CAR Group (ASX:CAR) is back in focus after its latest half year earnings, where revenue reached A$625.79 million and net profit came in at A$143.34 million, alongside a higher interim dividend. See our latest analysis for CAR Group. Despite the solid half year update and higher dividend, the share price has had a tougher run, with a 30 day share price return of a 17.67% decline and a year to date share price return of an 18.79% decline. The 1 year total shareholder return of a 32.67% decline...
ASX:NST
ASX:NSTMetals and Mining

Northern Star Resources (ASX:NST) Margin Expansion Reinforces Bullish Narratives Ahead Of H1 2026

Northern Star Resources (ASX:NST) has reported another solid set of numbers for H1 2026, with the latest reported half year in H2 2025 showing revenue of A$3.5b and basic EPS of A$0.68, underpinned by net income of A$833.3m. The company has seen revenue move from A$2.7b and EPS of A$0.38 in H2 2024 to A$2.9b and EPS of A$0.44 in H1 2025, then to A$3.5b and EPS of A$0.68 in H2 2025. This sets up a trailing twelve month net income of A$1.5b and EPS of A$1.16. With net profit margins running at...
ASX:PME
ASX:PMEHealthcare Services

Pro Medicus (ASX:PME) Net Margin Near 100% Reinforces Bullish Profitability Narratives

Pro Medicus (ASX:PME) has just posted its H1 2026 scorecard, headlined by trailing 12 month revenue of A$241.1 million alongside basic EPS of A$2.25, as the company continues to convert its imaging software footprint into solid top and bottom line figures. The company has seen revenue move from A$184.6 million to A$241.1 million across recent trailing 12 month periods, with basic EPS stepping up from A$0.94 to A$2.25 over the same horizon. Reported net profit margin has shifted sharply higher...
ASX:AMP
ASX:AMPDiversified Financial

AMP (ASX:AMP) EPS Rebound To A$0.039 Tests Bearish Margin And Valuation Narratives

AMP (ASX:AMP) has put fresh numbers on the table for FY 2025, reporting first half revenue of A$1.4 billion and basic EPS of A$0.039. This helps set the tone for how the year is shaping up after a mixed FY 2024. The company reported revenue of A$1.4 billion in the first half of 2024 and a loss of A$392 million in the second half. Over the same period, basic EPS moved from A$0.0387 to A$0.0185, before reaching A$0.039 in the latest half. For investors, a key focus now is how these results...
ASX:DYL
ASX:DYLOil and Gas

Deep Yellow (ASX:DYL) Valuation After New Uranium Find And Sudden CEO Change

What triggered the latest move in Deep Yellow shares? Deep Yellow (ASX:DYL) has been in focus after confirming uranium mineralisation at the S Bend prospect near its Tumas Project, as well as announcing that Managing Director and CEO John Borshoff will step down immediately. See our latest analysis for Deep Yellow. At the current share price of A$2.47, Deep Yellow has seen a 22.89% 1 month share price return and a 54.86% 3 month share price return. Its 1 year total shareholder return of...
ASX:NEU
ASX:NEUPharmaceuticals

Neuren Pharmaceuticals (ASX:NEU) Valuation Check As New Share Buy-Back Targets 5% Of Share Capital

Neuren Pharmaceuticals (ASX:NEU) has announced a new share buy-back program, authorising repurchases of up to 6,350,631 shares, or 5% of its issued capital, through to March 2027. See our latest analysis for Neuren Pharmaceuticals. The buy-back comes after a sharp 30 day share price return of around a 30% decline and a 90 day share price return of about a 29% decline, even though the 1 year and multi year total shareholder returns remain positive and very strong. This suggests recent selling...
ASX:EZL
ASX:EZLCapital Markets

3 ASX Penny Stocks With Market Caps Below A$600M

The Australian market has been experiencing a turbulent period, with concerns over artificial intelligence and tech sector volatility affecting investor sentiment. Despite these challenges, investors continue to seek opportunities in various sectors, including penny stocks. While the term 'penny stock' might feel outdated, it remains relevant as these smaller or newer companies can offer affordability and growth potential when backed by solid financials. Let's explore three ASX penny stocks...
ASX:WOW
ASX:WOWConsumer Retailing

Is Woolworths Group (ASX:WOW) Pricing Reflect Its Defensive Retail Role Today

If you are wondering whether Woolworths Group is fairly priced or offering value right now, you are not alone. This article is all about unpacking what the current share price really reflects. The stock recently closed at A$32.21, with returns of 1.9% over 7 days, 6.8% over 30 days, 9.4% year to date, 9.6% over 1 year, and 12.8% over 5 years, while the 3 year return sits at a 2.6% decline. Recent news around Woolworths Group has focused on its position as one of Australia's largest consumer...
ASX:S32
ASX:S32Metals and Mining

South32 (ASX:S32) EPS Loss In H1 2026 Tests Bullish Earnings Growth Narrative

South32 (ASX:S32) has put a mixed set of numbers on the table for H1 2026, with total revenue of US$2,797 million and a basic EPS loss of US$0.012, while trailing twelve month figures show revenue of US$5,906 million and basic EPS of US$0.087. Over the last three reported halves, the company has seen revenue move from US$2,459 million in H2 2024 to US$3,185 million in H1 2025 and US$2,797 million in H2 2025. EPS shifted from a loss of US$0.093 to a profit of US$0.083 and then back to a small...
ASX:ORG
ASX:ORGElectric Utilities

Origin Energy (ASX:ORG) Margin Compression Reinforces Cautious Earnings Narratives

Origin Energy (ASX:ORG) has put fresh numbers on the table for H1 2026, with trailing twelve month revenue at A$16.7b and Basic EPS of A$0.59. This sets the tone for how investors will read this latest update. Over recent halves the company has seen revenue move from A$8.2b in H2 2024 to A$8.8b in H1 2025 and A$8.5b in H2 2025, while Basic EPS shifted from A$0.23 to A$0.59 and then A$0.27. This gives a clearer view of how the top line and EPS have tracked into this result. With net profit...